scholarly article | Q13442814 |
P50 | author | Jan G. P. Tijssen | Q110910888 |
P2093 | author name string | Jan Baan | |
Robbert J de Winter | |||
Jan J Piek | |||
Martijn Meuwissen | |||
Peter Damman | |||
José P S Henriques | |||
Karel T Koch | |||
Niels J W Verouden | |||
Marije M Vis | |||
Johan Fischer | |||
Wichert J Kuijt | |||
Jan P van Straalen | |||
Marcel A M Beijk | |||
Nan van Geloven | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
biomarker | Q864574 | ||
P304 | page(s) | 29-36 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction | |
P478 | volume | 57 |
Q33553503 | Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction. |
Q37066826 | Almanac 2011: Acute Coronary Syndromes. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology |
Q38243626 | Application of chemometric techniques in search of clinically applicable biomarkers of disease |
Q48672802 | Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial |
Q55496889 | Baseline characteristics, management practices, and long-term outcomes among patients with first presentation acute myocardial infarction in the Second Gulf Registry of Acute Coronary Events (Gulf RACE-II). |
Q46712420 | C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity |
Q38062864 | Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction |
Q38543598 | Diagnostic and prognostic value of minor elevated cardiac troponin levels for percutaneous coronary intervention-related myocardial injury: a prospective, single-center and double-blind study |
Q39674294 | Difference in the Prognostic Impact of Left Ventricular Global Longitudinal Strain between Anterior and Nonanterior Myocardial Infarction |
Q35800571 | Gender difference in the prognostic value of estimated glomerular filtration rate at admission in ST-segment elevation myocardial infarction: a prospective cohort study. |
Q34020672 | High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. |
Q39126191 | High-sensitivity troponin level pre-catheterization predicts adverse cardiovascular outcomes after primary angioplasty for ST-elevation myocardial infarction |
Q38703283 | Is cardiac magnetic resonance necessary for prediction of left ventricular remodeling in patients with reperfused ST-segment elevation myocardial infarction? |
Q55059820 | Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention. |
Q39399883 | Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy |
Q48341520 | Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration |
Q35068612 | New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). |
Q40847015 | Older coronary thrombus is an independent predictor of 1-year mortality in acute myocardial infarction |
Q37609683 | Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis. |
Q47286885 | Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries |
Q33853247 | Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine |
Q47252903 | Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study |
Q31153054 | Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus |
Q35928009 | Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study |
Q86588599 | Relationship between admission blood glucose level and prognosis in elderly patients without previously known diabetes who undergo emergency non-cardiac surgery |
Q39000195 | Risk stratification after ST-segment elevation myocardial infarction. |
Q92572609 | ST-segment elevation myocardial infarction |
Q46760225 | Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction |
Q48665358 | Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction |
Q38777735 | The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality. |
Search more.